Showing
3 changed files
with
553 additions
and
553 deletions
| 1 | +latent membrane protein LMP 1 | ||
| 2 | +TGF- b | ||
| 3 | +SDC2 | ||
| 4 | +tissue factor | ||
| 5 | +JAK2 | ||
| 6 | +Serpin B4 | ||
| 7 | +WNT10A | ||
| 8 | +TGFb | ||
| 9 | +STAT1 | ||
| 10 | +pVHL | ||
| 11 | +bFGF | ||
| 12 | +Chop | ||
| 13 | +Stat3 | ||
| 14 | +Thymic stromal lymphopoietin | ||
| 15 | +pten | ||
| 16 | +ANG converting enzyme | ||
| 17 | +MT1 | ||
| 18 | +Semaphorin 7a | ||
| 19 | +HLF | ||
| 20 | +IL-10 | ||
| 21 | +PTEN | ||
| 22 | +Tb4 | ||
| 23 | +Vasohibin-2 | ||
| 24 | +TGF-beta1 | ||
| 25 | +TIMP-1 | ||
| 26 | +H19 | ||
| 27 | +STIP1 | ||
| 28 | +HSP27 | ||
| 29 | +TGF-b1 | ||
| 30 | +MMP-3 | ||
| 31 | +AKT | ||
| 32 | +ERK1/2 | ||
| 33 | +Serpin B3 | ||
| 34 | +miR-382 | ||
| 35 | +IL-1beta | ||
| 36 | +MKL1 | ||
| 37 | +E-cadherin | ||
| 38 | +endothelin-1 | ||
| 39 | +IL-6 | ||
| 40 | +ICAT | ||
| 41 | +MAPKAPK2 | ||
| 42 | +c-jun | ||
| 43 | +PEX13p | ||
| 44 | +BMPER | ||
| 45 | +MMP-1 | ||
| 1 | PTX-2 | 46 | PTX-2 |
| 2 | -Elk1 | 47 | +PDGB |
| 3 | -insulin-like growth factor-I | 48 | +MMP-7 |
| 4 | -protease-activated receptor-2 | 49 | +Smad3 |
| 5 | -SPP1 | 50 | +tsp1 |
| 6 | -LC3 | 51 | +ARPC2 |
| 7 | -Receptor for advanced glycation end products | 52 | +CD248 |
| 8 | -AT1 | 53 | +TRPV4 |
| 9 | -Enhancer of zeste homolog 2 | 54 | +Protease-activated receptor-1 |
| 10 | -ATG4B | 55 | +HDAC10 |
| 11 | -EZH2 | 56 | +mTORC2 |
| 12 | -p38 | 57 | +BMP |
| 13 | -Lefty A | 58 | +smad2/3 |
| 14 | -TF | 59 | +TGFb2 |
| 15 | -MyD88 | 60 | +bone morphogenetic protein 7 |
| 16 | -CD90 | 61 | +Hepatocyte growth factor |
| 17 | -Endothelin-1 | 62 | +hypoxia-inducible factor-1a |
| 18 | -Wnt1-inducible signaling protein 1 | 63 | +IL18 |
| 19 | -bone morphogenetic protein | 64 | +SMAD 3 |
| 20 | -tagln | 65 | +epidermal growth factor receptor |
| 21 | -IQGAP1 | 66 | +Sgpl1 |
| 22 | -PINK1 | 67 | +cartilage oligomeric matrix protein |
| 23 | -miR-140 | 68 | +Interleukin IL 8 |
| 24 | -Th1 | 69 | +superoxide dismutase 3 |
| 25 | -IGFBP-1 | 70 | +insulin-like growth factor-1 |
| 26 | -syndecan-2 | 71 | +IL-17A |
| 27 | -interleukin IL-13 | 72 | +MT3 |
| 28 | -IL-13 | 73 | +FRbeta |
| 74 | +IGF-2 | ||
| 75 | +IL8 | ||
| 76 | +ZO-1 | ||
| 77 | +IKKa | ||
| 78 | +SRF | ||
| 79 | +IL-31 | ||
| 80 | +transforming growth factor b-1 | ||
| 29 | Nox-4 | 81 | Nox-4 |
| 30 | -IGF-1 | 82 | +matrix metalloproteinase-9 |
| 83 | +serum response factor | ||
| 31 | transforming growth factor beta 1 | 84 | transforming growth factor beta 1 |
| 32 | -BMP3 | 85 | +serpine1 |
| 33 | -TGF-alpha | ||
| 34 | -Periostin | ||
| 35 | -AKT | ||
| 36 | -activin | ||
| 37 | -GLP-1 | ||
| 38 | -IGF-2 | ||
| 39 | -transforming growth factor TGF-beta 1 | ||
| 40 | -HIF-1a | ||
| 41 | -ANGII | ||
| 42 | -ACE | ||
| 43 | -Janus kinase type 2 | ||
| 44 | -bmp1 | ||
| 45 | -RhoA | ||
| 46 | -HLF | ||
| 47 | -Muc5ac | ||
| 48 | -MK2 | ||
| 49 | heme oxygenase-1 | 86 | heme oxygenase-1 |
| 50 | -Bcl-2 | ||
| 51 | -let-7d | ||
| 52 | -VASH-2 | ||
| 53 | -HSP27 | ||
| 54 | -transforming growth factor beta | ||
| 55 | -transforming growth factor b-1 | ||
| 56 | -transforming growth factor-beta | ||
| 57 | -superoxide dismutase 3 | ||
| 58 | -Transforming growth factor TGF-beta1 | ||
| 59 | -MMP1 | ||
| 60 | -TNF-a | ||
| 61 | -ECSOD | ||
| 62 | -Sulf1 | ||
| 63 | -MT1 | ||
| 64 | -CCN1 | ||
| 65 | -Histone deacetylase 6 | ||
| 66 | -Thy-1 | ||
| 67 | -CD19 | ||
| 68 | -HAI-2 | ||
| 69 | -ALK5 | ||
| 70 | -mTORC2 | ||
| 71 | -Krebs Von Den Lungen-6 | ||
| 72 | -tumor necrosis factor-alpha | ||
| 73 | -PTEN | ||
| 74 | -hypoxia-inducible factor 1a | ||
| 75 | -BMPR2 | ||
| 76 | -PI3K | ||
| 77 | -transforming growth factor-beta1 | ||
| 78 | -Mknk2 | ||
| 79 | -mir-21 | ||
| 80 | -STIP1 | ||
| 81 | -TIMP-1 | ||
| 82 | MT5-MMP | 87 | MT5-MMP |
| 83 | -Serpin B3/B4 | 88 | +Stanniocalcin-1 |
| 89 | +Caveolin-1 | ||
| 84 | HIF1a | 90 | HIF1a |
| 85 | -renin | 91 | +transforming growth factor-b1 |
| 86 | -NEU1 | 92 | +prostaglandin F PGF receptor |
| 87 | -MMP-1 | ||
| 88 | -Spiruchostatin A | ||
| 89 | -fibroblast growth factor receptor 2 | ||
| 90 | -SPARC | ||
| 91 | -Nox1 | ||
| 92 | -CC chemokine receptor 2 | ||
| 93 | -PEX13p | ||
| 94 | -C3a | ||
| 95 | -miR-31 | ||
| 96 | -folate receptor beta | ||
| 97 | -MAP3K19 | ||
| 98 | -transforming growth factor b | ||
| 99 | -c-Fos | ||
| 100 | -ET-B | ||
| 101 | -USP11 | ||
| 102 | -smad2/3 | ||
| 103 | -TNFa | ||
| 104 | -PAI-1 | ||
| 105 | -Wnt5A | ||
| 106 | -IGFBP-3 | ||
| 107 | platelet-derived growth factor isoforms PDGF A and B | 93 | platelet-derived growth factor isoforms PDGF A and B |
| 108 | -smooth muscle a-actin | 94 | +FGF-1 |
| 109 | -VCAM-1 | 95 | +FoxP3 |
| 110 | -Jun NH2-terminal kinase | 96 | +tissue inhibitors of metalloproteinases-1 |
| 111 | -miR-326 | 97 | +Egr-1 |
| 112 | -p21 | 98 | +NFkB |
| 113 | -MKL1 | 99 | +discoidin domain receptor 2 |
| 114 | -HDAC10 | 100 | +protease-activated receptor PAR-2 |
| 115 | -ITGB6 | 101 | +EZH2 |
| 116 | -LPA1 | 102 | +IQGAP1 |
| 117 | -histone deacetylase | 103 | +Transforming growth factor-b1 |
| 118 | -tgfbr1/2 | 104 | +Toll-like receptor 4 |
| 119 | -Transforming growth factor beta1 | 105 | +HDAC6 |
| 120 | -YY1 | 106 | +ltbp1/2 |
| 121 | -Caveolin-1 | 107 | +miR-487b |
| 122 | -TNC | 108 | +VEGF |
| 123 | -cyclosporine A | 109 | +Lin28B |
| 124 | -TGFB | 110 | +Oct-4 |
| 125 | -S1P | 111 | +serine protease |
| 126 | -Vimentin | 112 | +150-kDa oxygen-regulated protein |
| 127 | -Transforming growth factor beta | 113 | +MicroRNA miR-221 |
| 128 | -DDR2 | 114 | +tgfb2 |
| 115 | +CXCL10 | ||
| 116 | +Lefty A | ||
| 117 | +phosphoinositide 3-kinase | ||
| 118 | +MIG | ||
| 119 | +High mobility group AT-hook 2 | ||
| 120 | +FAK | ||
| 121 | +HAI-1 | ||
| 122 | +miR-9-5p | ||
| 123 | +TG2 | ||
| 129 | p21waf1 | 124 | p21waf1 |
| 130 | -IL-1beta | 125 | +Thymosin b4 |
| 131 | -3-hydroxy-3-methylglutaryl CoenzymeA HMG CoA reductase | 126 | +IL-13 |
| 132 | -N -cadherin | 127 | +Syndecan-2 |
| 133 | -NOX4 | 128 | +BMP-5 |
| 134 | -miR-134 | 129 | +YY1 |
| 135 | -serum amyloid P | 130 | +SNAI2 |
| 131 | +ORP150 | ||
| 132 | +claudins-1, -3, and -5 | ||
| 133 | +mir-21 | ||
| 134 | +matrix metalloproteinase-3 | ||
| 135 | +b2 -AR | ||
| 136 | +interleukin-6 | ||
| 137 | +TGFb1 | ||
| 136 | lymphotactin | 138 | lymphotactin |
| 137 | -Transforming growth factor TGF-b1 | 139 | +focal adhesion kinase |
| 138 | -TGFbeta | 140 | +FGF-2 |
| 139 | -Keap1 | 141 | +miR -221 |
| 140 | -MT3 | ||
| 141 | -MMP-3 | ||
| 142 | -CUX1 | ||
| 143 | -Bax inhibitor-1 | ||
| 144 | -LEF/TCF | ||
| 145 | -matrix metalloproteinase-7 | ||
| 146 | -MCP-1 | ||
| 147 | -PPAR | ||
| 148 | TbetaRII | 142 | TbetaRII |
| 149 | -miR-30a | 143 | +b2 -adrenoceptors |
| 150 | -bone morphogenetic protein 7 | 144 | +STUB1 |
| 151 | -Mitogen-activated protein kinase-activated protein kinase-2 | 145 | +LC3 |
| 152 | -miR-17 92 | 146 | +WISP1 |
| 153 | -TNFSF14 | ||
| 154 | -CD206 | ||
| 155 | -CTGF | ||
| 156 | -Galectin-3 | ||
| 157 | ACTA2 | 147 | ACTA2 |
| 158 | -Osteopontin | 148 | +SpA |
| 149 | +Spiruchostatin A | ||
| 150 | +SNAI1 | ||
| 151 | +CBP | ||
| 152 | +AP-1 | ||
| 153 | +SMAD3 | ||
| 154 | +Extracellular Matrix Metalloproteinase Inducer | ||
| 155 | +BMP-15 | ||
| 156 | +signal transducer and activator of transcription 3 | ||
| 157 | +TGFbeta | ||
| 158 | +3-hydroxy-3-methylglutaryl CoenzymeA HMG CoA reductase | ||
| 159 | +Hsp90 | ||
| 160 | +Smad2/3 | ||
| 161 | +IL-8 | ||
| 162 | +thrombin | ||
| 163 | +peroxisome proliferator-activated receptor-y | ||
| 164 | +ET-B | ||
| 165 | +BARD1 | ||
| 166 | +periostin | ||
| 167 | +CD55 | ||
| 168 | +AT2 | ||
| 169 | +CD90 | ||
| 170 | +TGF beta1 | ||
| 171 | +Serpin B3/B4 | ||
| 172 | +alpha-SMA | ||
| 173 | +MMP1 | ||
| 174 | +c-Jun | ||
| 175 | +CRP1 | ||
| 176 | +mTOR | ||
| 177 | +LTBP] 1, 2, and 4 | ||
| 178 | +IL8, -6, and -1B | ||
| 179 | +YAP | ||
| 180 | +lymphotoxin beta receptor | ||
| 181 | +CCN5 | ||
| 159 | transforming growth factor-beta 1 | 182 | transforming growth factor-beta 1 |
| 160 | -TGF-b1 | ||
| 161 | -SGPL1 | ||
| 162 | -Smad3 | ||
| 163 | transient receptor potential vanilloid 4 | 183 | transient receptor potential vanilloid 4 |
| 164 | -NOS | 184 | +SFTPC |
| 165 | -CXCL9 | 185 | +alpha-smooth muscle actin |
| 166 | -NADPH oxidase 4 | 186 | +TOB2 |
| 167 | -High mobility group AT-hook 2 | 187 | +SMA |
| 168 | -beta-catenin | 188 | +matrix metalloprotease-1 |
| 169 | -STC1 | 189 | +IL-18 |
| 170 | -Membrane-type MT-MMPs | 190 | +HO-1 |
| 171 | -follistatin | 191 | +SMAD2/3 |
| 172 | -IL8 | 192 | +Endothelin-1 |
| 173 | -miR-424 | 193 | +cyclosporine A |
| 194 | +megakaryoblastic leukemia 1 | ||
| 195 | +MT2 | ||
| 174 | Pentraxin-2 | 196 | Pentraxin-2 |
| 175 | -miR-21 | 197 | +matrix metalloproteinase MMP-9 |
| 176 | -Toll-like receptor 4 | 198 | +Vimentin |
| 199 | +beta-catenin | ||
| 200 | +leucine-rich alpha-2 glycoprotein | ||
| 201 | +HMGA2 | ||
| 202 | +Wnt5A | ||
| 203 | +TbRII | ||
| 204 | +N -cadherin | ||
| 177 | interleukin IL-6 | 205 | interleukin IL-6 |
| 178 | -cytokeratin 19 | 206 | +CD44 |
| 179 | -ANG converting enzyme | 207 | +serum amyloid P |
| 180 | -tissue factor | 208 | +fibroblast growth factor receptor 2 |
| 181 | -TRPV4 | 209 | +PIAS4 |
| 182 | -FOXF1 | 210 | +beclin 1 |
| 183 | -C/EBP homologous protein | 211 | +p38 |
| 184 | -Cysteine-rich protein 1 | 212 | +TNC |
| 185 | -thrombin | 213 | +Transforming growth factor-beta1 |
| 186 | -insulin-like growth factor I | 214 | +MK2 |
| 187 | -ALK-5 | 215 | +CC chemokine receptor 2 |
| 188 | -ZO-1 | 216 | +HGF |
| 189 | -C3aR | 217 | +Nox1 |
| 190 | -SNAI2 | 218 | +Forkhead Box F1 |
| 191 | -TIAM1 | ||
| 192 | -SMAD2/3 | ||
| 193 | -TGFb-1 | ||
| 194 | -a-smooth muscle actin | ||
| 195 | -latent membrane protein LMP 1 | ||
| 196 | -miR | ||
| 197 | -HSP47 | ||
| 198 | -mothers against decapentaplegic homolog 3 | ||
| 199 | -RANTES | ||
| 200 | -TNF-alpha | ||
| 201 | -YKL-40 | ||
| 202 | -Smad2/3 | ||
| 203 | -AKT2 | ||
| 204 | -Nox4 | ||
| 205 | -Angiotensin II | ||
| 206 | -transforming growth factor b expression | ||
| 207 | -CXCL10 | ||
| 208 | -BMP-5 | ||
| 209 | -IFN-gammaR | ||
| 210 | -miR-1343 | ||
| 211 | -plasminogen activator inhibitor 1 | ||
| 212 | Rpn6 | 219 | Rpn6 |
| 213 | -lysyl oxidase | 220 | +TLR4 |
| 214 | -ltbp1/2 | 221 | +Ost-4 |
| 215 | -IL-6 | 222 | +KCa3.1 |
| 216 | -CCN5 | 223 | +Col1a2 |
| 217 | -Extracellular Matrix Metalloproteinase Inducer | 224 | +phosphoglycerate dehydrogenase |
| 218 | -NOX-2 | 225 | +miR-17 92 |
| 219 | -Stat3 | 226 | +JNK |
| 220 | -Yin Yang 1 | 227 | +extent, type B receptors |
| 221 | -phosphoinositide 3-kinase | 228 | +caveolin-1 |
| 222 | -transforming growth factor b1 | 229 | +GLP-1 |
| 223 | -NOX-4 | 230 | +TNF-a |
| 231 | +Endosialin | ||
| 232 | +TGF-b | ||
| 233 | +miR-134 | ||
| 224 | Transforming growth factor-b | 234 | Transforming growth factor-b |
| 225 | -Aortic carboxypeptidase-like protein | 235 | +IGFBP-2 |
| 226 | -FIEL1 | 236 | +ECSOD |
| 227 | -miR-154 | 237 | +Bcl-2 |
| 228 | -Sema7a | 238 | +il12p40 |
| 229 | -matrix metalloprotease-1 | 239 | +transforming growth factor TGF-beta 1 |
| 230 | -PEX13 | 240 | +IP-10 |
| 231 | -COL1A1 | 241 | +NOX4 |
| 232 | -TNFalpha | 242 | +cytokeratin 19 |
| 233 | -Matriptase | 243 | +PARP |
| 244 | +mir-155 | ||
| 245 | +Vascular endothelial growth factor | ||
| 246 | +HIF-1a | ||
| 247 | +EMMPRIN | ||
| 248 | +Sulf1 | ||
| 249 | +VASH-2 | ||
| 250 | +p300 | ||
| 251 | +cyclooxygenase 2 | ||
| 252 | +Wnt1-inducible signaling protein 1 | ||
| 234 | EGFR | 253 | EGFR |
| 235 | -HGF | 254 | +collagen Col1a1 |
| 236 | -Bax | 255 | +tgfbr1/2 |
| 237 | -interleukin-6 | 256 | +CXCL1 |
| 238 | -CCL2 | 257 | +COL1A1 |
| 239 | -MMP-12 | 258 | +T beta RII |
| 240 | -IKKa | ||
| 241 | -miR-26a | ||
| 242 | -SMAD2 | ||
| 243 | -matriptase | ||
| 244 | -semaphorin-7A | ||
| 245 | -Syndecan-2 | ||
| 246 | -ILK | ||
| 247 | -beta-galactosidase | ||
| 248 | -LRG | ||
| 249 | Cthrc1 | 259 | Cthrc1 |
| 250 | -transforming growth factor beta1 | 260 | +Sulf2 |
| 251 | -MAPKAPK2 | 261 | +NOX-2 |
| 252 | -suppressor of cytokine signaling 1 | 262 | +TGFBR2 |
| 253 | -Serpin B3 | 263 | +thrombospondin-1 |
| 254 | -Pigment epithelium-derived factor | 264 | +folate receptor beta |
| 255 | -JNK | 265 | +ILK |
| 256 | -Transforming growth factor-beta | 266 | +NF-kB |
| 257 | -CD25 | 267 | +matriptase |
| 258 | -PAR-2 | 268 | +YKL-40 |
| 259 | -Thymosin b4 | 269 | +CCN2 |
| 260 | -Activin | 270 | +ErbB2 |
| 261 | E -cadherin | 271 | E -cadherin |
| 272 | +CTGF | ||
| 273 | +Transforming growth factor b | ||
| 274 | +IL10 | ||
| 275 | +HSP90 | ||
| 276 | +CD8 | ||
| 277 | +Transforming growth factor TGF-beta1 | ||
| 278 | +hepatocyte growth factor | ||
| 279 | +Janus kinase type 2 | ||
| 280 | +TGFB | ||
| 281 | +Th1 | ||
| 282 | +SMAD2 | ||
| 283 | +BMP3 | ||
| 284 | +SAP | ||
| 285 | +hypoxia-inducible factor 1a | ||
| 262 | BCL-2 | 286 | BCL-2 |
| 263 | -beta 1 integrin | 287 | +CD19 |
| 264 | -Toll-like receptor 9 | 288 | +SGPL1 |
| 265 | -BARD1 | 289 | +il17a |
| 266 | -MIG | 290 | +microRNA miR-155 |
| 267 | -Fas ligand | 291 | +Mmp19 |
| 268 | -epidermal growth factor receptor | 292 | +Akt2 |
| 269 | -glucagon like peptide-1 | 293 | +poly-ADP ribose polymerase |
| 270 | -extracellular superoxide dismutase | 294 | +C5a |
| 271 | -Chop | 295 | +bone morphogenetic protein |
| 272 | -EMT | 296 | +PINK1 |
| 273 | -Smad2 | 297 | +TGF-beta 1 |
| 274 | -ET-1 | 298 | +Histone deacetylase 6 |
| 275 | -claudins-1, -3, and -5 | 299 | +transforming growth factor-b |
| 276 | -Oct-4 | ||
| 277 | Lrp5 | 300 | Lrp5 |
| 278 | -extent, type B receptors | 301 | +Enhancer of zeste homolog 2 |
| 279 | -IL-31 | 302 | +SIRT6 |
| 280 | -TGF beta1 | 303 | +ACLP |
| 281 | -integrin-linked kinase | 304 | +miR-140 |
| 282 | -NFkB | ||
| 283 | -TGFBR2 | ||
| 284 | -PPAR-a | ||
| 285 | -PDGF-b | ||
| 286 | -transgelin | ||
| 287 | -HAI-1 | ||
| 288 | -Trx | ||
| 289 | -PAR-1 | ||
| 290 | miR-338 | 305 | miR-338 |
| 291 | -n-cadherin | 306 | +Smad4 |
| 292 | -interleukin-8 | 307 | +AAG |
| 293 | -prostaglandin F PGF receptor | 308 | +plasminogen activator inhibitor-1 |
| 294 | -collagen Col1a1 | 309 | +IGFBP-3 |
| 295 | -PHLPP | 310 | +follistatin |
| 296 | -FRNK | 311 | +S1P |
| 297 | -thrombospondin-1 | 312 | +CD25 |
| 298 | -Semaphorin 7a | 313 | +TNFalpha |
| 299 | -signal transducer and activator of transcription 3 | 314 | +TGF-beta |
| 300 | -BMP-15 | 315 | +miR-29a |
| 301 | -cyclooxygenase 2 | 316 | +LEF/TCF |
| 302 | -Forkhead Box F1 | 317 | +Wt1 |
| 303 | -HMGA2 | 318 | +TGFb-1 |
| 304 | -b2 -AR | 319 | +ALK5 |
| 305 | -CD34 | 320 | +transgelin |
| 306 | -pVHL | 321 | +Atg4b |
| 307 | -BI-1 | 322 | +interleukin IL-1b |
| 308 | -C1q | 323 | +igf1 |
| 309 | -Serpin B4 | 324 | +RhoA |
| 310 | -H19 | 325 | +interleukin IL-1beta |
| 311 | -STUB1 | 326 | +mPGES-1 |
| 312 | -FoxP3 | 327 | +Nox4 |
| 313 | -serum albumin HSA-thioredoxin 1 | 328 | +TLR9 |
| 314 | -SOD3 | 329 | +PAI-1 |
| 315 | -p65 | ||
| 316 | -cytosolic phospholipase A2 | ||
| 317 | -TGF-b-1 | ||
| 318 | -Fstl1 | ||
| 319 | ET-A | 330 | ET-A |
| 320 | -PDGFR | 331 | +Smad 7 |
| 321 | -vimentin | 332 | +Semaphorin-7A |
| 322 | -BMP-7 | 333 | +IGF-I |
| 323 | -PDGF-B | ||
| 324 | -Rictor | ||
| 325 | -WISP1 | ||
| 326 | -interleukin-1beta | ||
| 327 | -mTOR | ||
| 328 | -focal adhesion kinase-related nonkinase | ||
| 329 | -TSLP | ||
| 330 | -IL-10 | ||
| 331 | -MMP-7 | ||
| 332 | -Transforming growth factor-beta1 | ||
| 333 | -Akt | ||
| 334 | -SpA | ||
| 335 | -CD11c | ||
| 336 | -Foxp-3 | ||
| 337 | -PARP | ||
| 338 | -STAT3 | ||
| 339 | -MMP2 | ||
| 340 | -PDGB | ||
| 341 | -tsp1 | ||
| 342 | -discoidin domain receptor 2 | ||
| 343 | CD4 | 334 | CD4 |
| 344 | -FGF-1 | 335 | +TNF-alpha |
| 345 | -E-cadherin | 336 | +Insulin-like growth factor-1 |
| 346 | -TGFb | 337 | +Sema7a |
| 338 | +fibronectin | ||
| 339 | +terminal deoxynucleotidyl transferase | ||
| 340 | +cytosolic phospholipase A2 | ||
| 341 | +TNFa | ||
| 342 | +PEX13 | ||
| 343 | +PDGF-B | ||
| 344 | +NEU1 | ||
| 347 | tenascin-C | 345 | tenascin-C |
| 348 | -Transforming growth factor beta 1 | 346 | +CUX1 |
| 347 | +Transforming growth factor beta | ||
| 348 | +acyl-CoA oxidase 1 | ||
| 349 | +Fstl1 | ||
| 350 | +C5aR | ||
| 351 | +ANGII | ||
| 352 | +ITGB6 | ||
| 353 | +Angiotensin II | ||
| 349 | Interleukin 17A | 354 | Interleukin 17A |
| 355 | +Pigment epithelium-derived factor | ||
| 356 | +transforming growth factor-beta1 | ||
| 357 | +Snail | ||
| 358 | +ACE | ||
| 359 | +SPP1 | ||
| 360 | +vimentin | ||
| 361 | +Matriptase | ||
| 362 | +P53 | ||
| 363 | +MMP-2 | ||
| 364 | +TGF-b-1 | ||
| 365 | +nuclear factor erythroid 2-related factor 2 | ||
| 366 | +Periostin | ||
| 350 | PDGF-A | 367 | PDGF-A |
| 351 | -SAP | 368 | +Transforming growth factor-beta |
| 352 | -Transglutaminase 2 | 369 | +Sema 7a |
| 370 | +tagln | ||
| 371 | +monocyte chemoattractant protein 1 | ||
| 372 | +GR | ||
| 373 | +Collagen Triple Helix Repeat-Containing-1 | ||
| 374 | +Thy-1 | ||
| 375 | +interleukin IL-13 | ||
| 376 | +C/EBP homologous protein | ||
| 377 | +RAGE | ||
| 378 | +miR-1343 | ||
| 379 | +transforming growth factor beta-1 | ||
| 380 | +b-FGF | ||
| 353 | beta-gal | 381 | beta-gal |
| 354 | -smoothened | 382 | +MiR-338 |
| 355 | -miR-5100 | 383 | +Fas ligand |
| 356 | -alpha-smooth muscle actin | 384 | +semaphorin-7A |
| 357 | -bFGF | 385 | +SMAD-3 |
| 358 | -connective tissue growth factor | 386 | +histone deacetylase |
| 359 | -COL1A2 | 387 | +bmp1 |
| 360 | -SRF | ||
| 361 | -Thymic stromal lymphopoietin | ||
| 362 | -TGF-beta | ||
| 363 | -tissue inhibitors of metalloproteinases-1 | ||
| 364 | -IL18 | ||
| 365 | -Janus kinase 2 | ||
| 366 | -ERK1/2 | ||
| 367 | -KL-6 | ||
| 368 | -CCN2 | ||
| 369 | -HO-1 | ||
| 370 | -endothelin type A receptors | ||
| 371 | -igf1 | ||
| 372 | -nuclear factor erythroid 2-related factor 2 | ||
| 373 | -MT2 | ||
| 374 | -C5aR | ||
| 375 | -CXCL1 | ||
| 376 | COMP | 388 | COMP |
| 377 | -Mkl1 | ||
| 378 | -TbRII | ||
| 379 | VASH-1 | 389 | VASH-1 |
| 380 | -IGF-I | ||
| 381 | -Insulin-like growth factor binding protein-3 | ||
| 382 | -Collagen Triple Helix Repeat-Containing-1 | ||
| 383 | -TGFbeta1 | ||
| 384 | -CAV1 | ||
| 385 | -PEDF | ||
| 386 | -terminal deoxynucleotidyl transferase | ||
| 387 | -b2 -adrenoceptors | ||
| 388 | -X-linked inhibitor of apoptosis | ||
| 389 | -leucine-rich alpha-2 glycoprotein | ||
| 390 | -PAI1 | ||
| 391 | -CD55 | ||
| 392 | -miR-29a | ||
| 393 | -Sema 7a | ||
| 394 | -FRbeta | ||
| 395 | -Semaphorin-7A | ||
| 396 | -AT2 | ||
| 397 | -caveolin-1 | ||
| 398 | -V-ATPase | ||
| 399 | -poly-ADP ribose polymerase | ||
| 400 | -Egr-1 | ||
| 401 | -transforming growth factor beta-1 | ||
| 402 | -IL6 | ||
| 403 | -AP-1 | ||
| 404 | -Akt2 | ||
| 405 | -Endosialin | ||
| 406 | -phosphoglycerate dehydrogenase | ||
| 407 | -mPGES-1 | ||
| 408 | -CXCL12 | ||
| 409 | -Atg4b | ||
| 410 | -SNAI1 | ||
| 411 | -megakaryoblastic leukemia 1 | ||
| 412 | -acyl-CoA oxidase 1 | ||
| 413 | -STAT1 | ||
| 414 | -P53 | ||
| 415 | -pten | ||
| 416 | -Protease-activated receptor-1 | ||
| 417 | -cPLA2 | ||
| 418 | -Interleukin IL 8 | ||
| 419 | -Sgpl1 | ||
| 420 | -CD44 | ||
| 421 | -Snail | ||
| 422 | -Tb4 | ||
| 423 | -hyaluronan synthase 2 | ||
| 424 | -MMP-9 | ||
| 425 | -T beta RII | ||
| 426 | -Vascular endothelial growth factor | ||
| 427 | -JAK2 | ||
| 428 | -CD117 | ||
| 429 | -Tumor necrosis factor-alpha | ||
| 430 | -protease-activated receptor PAR-2 | ||
| 431 | -miR-9-5p | ||
| 432 | -Wt1 | ||
| 433 | -miR-487b | ||
| 434 | -Ost-4 | ||
| 435 | -WNT10A | ||
| 436 | -mir-155 | ||
| 437 | -HSP90 | ||
| 438 | -glucocorticoid receptor | ||
| 439 | -il17a | ||
| 440 | -serine protease | ||
| 441 | -IP-10 | ||
| 442 | -IgG1 | ||
| 443 | -alpha-SMA | ||
| 444 | -SMA | ||
| 445 | -matrix metalloproteinase-3 | ||
| 446 | -c-Jun | ||
| 447 | -TOB2 | ||
| 448 | -insulin-like growth factor-1 | ||
| 449 | -p63 | ||
| 450 | -WNT1-inducible signaling pathway protein 1 | ||
| 451 | -TGF-beta1 | ||
| 452 | JunD | 390 | JunD |
| 453 | -CRP1 | 391 | +Mkl1 |
| 454 | -focal adhesion kinase | 392 | +HSP47 |
| 455 | -AAG | 393 | +NOX-4 |
| 456 | -ARPC2 | 394 | +CD68 |
| 457 | -miR-127 | 395 | +Rictor |
| 458 | -monocyte chemoattractant protein 1 | 396 | +PEDF |
| 459 | -FAK | 397 | +IL-4 |
| 460 | -Lin28B | 398 | +Wilms' tumor 1 |
| 461 | -secreted protein acidic and rich in cysteine | 399 | +interleukin-1beta |
| 462 | -cartilage oligomeric matrix protein | 400 | +transforming growth factor b |
| 463 | -galectin-3 | 401 | +PPAR |
| 464 | -EMMPRIN | 402 | +transforming growth factor b1 |
| 465 | -ErbB2 | 403 | +KL-6 |
| 466 | -Sulf2 | 404 | +CD46 |
| 467 | -SIRT6 | ||
| 468 | -NF-kB | ||
| 469 | -c-jun | ||
| 470 | -SMAD3 | ||
| 471 | -HDAC6 | ||
| 472 | -miR-455 | ||
| 473 | -periostin | ||
| 474 | -Renin | ||
| 475 | -protein kinase B | ||
| 476 | -PHGDH | ||
| 477 | -PDGF-A and -B | ||
| 478 | -Hepatocyte growth factor | ||
| 479 | -serum response factor | ||
| 480 | -FGF-2 | ||
| 481 | -MRTF-A | ||
| 482 | -CBP | ||
| 483 | -Mmp19 | ||
| 484 | -TGFb2 | ||
| 485 | annexin V | 405 | annexin V |
| 486 | -SDC2 | 406 | +matrix metalloproteinase-7 |
| 487 | -IFN-gamma | 407 | +miR-3107 |
| 488 | -interleukin IL-1beta | 408 | +MyD88 |
| 489 | -ORP150 | 409 | +tumor necrosis factor-alpha |
| 490 | -BMP-8B | 410 | +Transforming growth factor b-1 |
| 491 | -TGFb1 | 411 | +miR-326 |
| 492 | -CXCR3 | 412 | +ET-1 |
| 493 | -transforming growth factor -b1 | 413 | +Trx |
| 414 | +Akt | ||
| 415 | +BI-1 | ||
| 416 | +STAT3 | ||
| 417 | +STC1 | ||
| 418 | +miR-127 | ||
| 419 | +PDGFR | ||
| 420 | +MCP-1 | ||
| 421 | +PDGF-A and -B | ||
| 422 | +cPLA2 | ||
| 423 | +Itgb6 | ||
| 424 | +LRP5 | ||
| 425 | +Krebs Von Den Lungen-6 | ||
| 426 | +transforming growth factor TGF-beta1 | ||
| 427 | +USP11 | ||
| 428 | +PPAR-a | ||
| 429 | +NADPH oxidase 4 | ||
| 430 | +glucagon like peptide-1 | ||
| 431 | +insulin-like growth factor I | ||
| 432 | +Osteopontin | ||
| 433 | +PDGF-b | ||
| 434 | +Jun NH2-terminal kinase | ||
| 494 | Transforming growth factor-beta 1 | 435 | Transforming growth factor-beta 1 |
| 495 | -T-cell lymphoma invasion and metastasis 1 | 436 | +caspase-3 |
| 496 | -beclin 1 | 437 | +PAR-1 |
| 497 | -IL-18 | 438 | +tumor necrosis factor alpha |
| 498 | -fibroblast growth factor-2 | 439 | +miR-31 |
| 499 | -p300 | 440 | +insulin-like growth factor-I |
| 500 | -miR-382 | 441 | +miR-424 |
| 501 | -IL-4 | 442 | +FRNK |
| 502 | -CD8 | 443 | +Keap1 |
| 503 | -transforming growth factor-b | 444 | +LRG |
| 504 | -Wilms' tumor 1 | 445 | +integrin-linked kinase |
| 505 | -ERK | ||
| 506 | -Hsp90 | ||
| 507 | -Connective tissue growth factor | ||
| 508 | -IGFBP-2 | ||
| 509 | -endothelin-1 | ||
| 510 | -b-catenin | ||
| 511 | -mPAP | ||
| 512 | -matrix metalloproteinase MMP-9 | ||
| 513 | -PIAS4 | ||
| 514 | -plasminogen activator inhibitor-1 | ||
| 515 | -MicroRNA miR-221 | ||
| 516 | -b-FGF | ||
| 517 | -KCa3.1 | ||
| 518 | -YAP | ||
| 519 | -SphK | ||
| 520 | -CD248 | ||
| 521 | -C5a | ||
| 522 | -gremlin | ||
| 523 | -SFTPC | ||
| 524 | -CCR2 | ||
| 525 | -ACLP | ||
| 526 | -il12p40 | ||
| 527 | -fibronectin | ||
| 528 | -Col1a2 | ||
| 529 | -Gremlin | ||
| 530 | -TGF-b | ||
| 531 | -miR-410 | ||
| 532 | -Vasohibin-2 | ||
| 533 | -Cub domain containing protein 1 | ||
| 534 | SOCS1 | 446 | SOCS1 |
| 535 | -transforming growth factor TGF-beta1 | ||
| 536 | -TGF-beta 1 | ||
| 537 | -miR -221 | ||
| 538 | -Smad4 | ||
| 539 | a-SMA | 447 | a-SMA |
| 540 | -BMP | ||
| 541 | -transforming growth factor-b1 | ||
| 542 | -CD46 | ||
| 543 | -matrix metalloproteinase-9 | ||
| 544 | -tgfb2 | ||
| 545 | -RAGE | ||
| 546 | -GR | ||
| 547 | -Itgb6 | ||
| 548 | -TGF- b | ||
| 549 | -vascular endothelial growth factor | ||
| 550 | -microRNA miR-155 | ||
| 551 | -peroxisome proliferator-activated receptor-y | ||
| 552 | 5-HTR1A/B and 5-HTR2B | 448 | 5-HTR1A/B and 5-HTR2B |
| 553 | sL1 | 449 | sL1 |
| 554 | -interleukin IL-1b | 450 | +Mitogen-activated protein kinase-activated protein kinase-2 |
| 555 | -Transforming growth factor-b1 | 451 | +miR |
| 556 | -Transforming growth factor b-1 | 452 | +CXCL12 |
| 453 | +Galectin-3 | ||
| 557 | TGFB1 | 454 | TGFB1 |
| 558 | -miR-3107 | 455 | +mPAP |
| 559 | -Transforming growth factor b | 456 | +transforming growth factor b expression |
| 560 | -lymphotoxin beta receptor | 457 | +focal adhesion kinase-related nonkinase |
| 561 | -Smad 7 | 458 | +BMP-7 |
| 562 | -Stanniocalcin-1 | 459 | +Receptor for advanced glycation end products |
| 563 | -IP10 | 460 | +Renin |
| 564 | -LTBP] 1, 2, and 4 | 461 | +MMP2 |
| 565 | -TG2 | 462 | +Nrf2 |
| 566 | -IL-17A | 463 | +miR-154 |
| 567 | -SMAD 3 | 464 | +Transglutaminase 2 |
| 568 | -tumor necrosis factor alpha | 465 | +miR-21 |
| 569 | -IL-8 | 466 | +plasminogen activator inhibitor 1 |
| 467 | +Cub domain containing protein 1 | ||
| 468 | +TGFbeta1 | ||
| 469 | +IgG1 | ||
| 470 | +EMT | ||
| 471 | +PI3K | ||
| 472 | +glucocorticoid receptor | ||
| 473 | +transforming growth factor beta | ||
| 474 | +Bax | ||
| 475 | +Cysteine-rich protein 1 | ||
| 476 | +miR-26a | ||
| 477 | +lysyl oxidase | ||
| 478 | +Janus kinase 2 | ||
| 479 | +mothers against decapentaplegic homolog 3 | ||
| 480 | +Toll-like receptor 9 | ||
| 481 | +VCAM-1 | ||
| 482 | +NOS | ||
| 483 | +c-Fos | ||
| 570 | cyclin D1 | 484 | cyclin D1 |
| 571 | -IL8, -6, and -1B | 485 | +TSLP |
| 572 | -150-kDa oxygen-regulated protein | 486 | +IGF-1 |
| 573 | -hypoxia-inducible factor-1a | 487 | +ALK-5 |
| 574 | -COX-2 | 488 | +Tumor necrosis factor-alpha |
| 575 | -Insulin-like growth factor-1 | 489 | +CD11c |
| 576 | -hepatocyte growth factor | 490 | +C3aR |
| 577 | -MiR-338 | 491 | +miR-455 |
| 578 | -TLR4 | 492 | +gremlin |
| 493 | +Transforming growth factor beta 1 | ||
| 494 | +TIAM1 | ||
| 495 | +p63 | ||
| 496 | +p21 | ||
| 497 | +IP10 | ||
| 498 | +MRTF-A | ||
| 499 | +CD206 | ||
| 500 | +C3a | ||
| 501 | +n-cadherin | ||
| 502 | +X-linked inhibitor of apoptosis | ||
| 503 | +Membrane-type MT-MMPs | ||
| 504 | +RANTES | ||
| 505 | +SOD3 | ||
| 506 | +activin | ||
| 507 | +V-ATPase | ||
| 508 | +transforming growth factor -b1 | ||
| 509 | +CCN1 | ||
| 510 | +CCl4 | ||
| 579 | CDCP1 | 511 | CDCP1 |
| 580 | -ICAT | 512 | +miR-410 |
| 581 | -BMPER | 513 | +beta-galactosidase |
| 582 | -VEGF | 514 | +suppressor of cytokine signaling 1 |
| 583 | -MMP-2 | 515 | +AKT2 |
| 584 | -IL10 | 516 | +C1q |
| 585 | -TLR9 | 517 | +serum albumin HSA-thioredoxin 1 |
| 586 | -SMAD-3 | ||
| 587 | -CD68 | ||
| 588 | IL-1b | 518 | IL-1b |
| 589 | -LRP5 | 519 | +vascular endothelial growth factor |
| 590 | -caspase-3 | 520 | +protein kinase B |
| 591 | -CCl4 | 521 | +BMP-8B |
| 592 | -serpine1 | 522 | +Bax inhibitor-1 |
| 523 | +Yin Yang 1 | ||
| 524 | +miR-30a | ||
| 525 | +Smad2 | ||
| 526 | +CD117 | ||
| 527 | +syndecan-2 | ||
| 528 | +DDR2 | ||
| 593 | IL-17 | 529 | IL-17 |
| 594 | -Nrf2 | 530 | +COX-2 |
| 531 | +transforming growth factor-beta | ||
| 532 | +Foxp-3 | ||
| 533 | +smooth muscle a-actin | ||
| 534 | +smoothened | ||
| 535 | +Connective tissue growth factor | ||
| 536 | +CCR2 | ||
| 537 | +interleukin-8 | ||
| 538 | +PHLPP | ||
| 539 | +SphK | ||
| 540 | +transforming growth factor beta1 | ||
| 541 | +Elk1 | ||
| 542 | +p65 | ||
| 543 | +Activin | ||
| 544 | +MAP3K19 | ||
| 545 | +AT1 | ||
| 546 | +galectin-3 | ||
| 547 | +Gremlin | ||
| 548 | +TGF-alpha | ||
| 549 | +PAI1 | ||
| 550 | +IFN-gamma | ||
| 551 | +MMP-9 | ||
| 552 | +SPARC | ||
| 553 | +IFN-gammaR | ||
| 554 | +CCL2 | ||
| 555 | +TNFSF14 | ||
| 556 | +CXCR3 | ||
| 557 | +BMPR2 | ||
| 558 | +extracellular superoxide dismutase | ||
| 559 | +FIEL1 | ||
| 560 | +IL6 | ||
| 561 | +fibroblast growth factor-2 | ||
| 562 | +connective tissue growth factor | ||
| 563 | +Muc5ac | ||
| 564 | +b-catenin | ||
| 565 | +MMP-12 | ||
| 566 | +let-7d | ||
| 567 | +ATG4B | ||
| 568 | +TF | ||
| 569 | +Transforming growth factor beta1 | ||
| 570 | +hyaluronan synthase 2 | ||
| 571 | +Aortic carboxypeptidase-like protein | ||
| 572 | +secreted protein acidic and rich in cysteine | ||
| 573 | +renin | ||
| 574 | +T-cell lymphoma invasion and metastasis 1 | ||
| 575 | +CAV1 | ||
| 576 | +endothelin type A receptors | ||
| 577 | +miR-5100 | ||
| 578 | +FOXF1 | ||
| 579 | +beta 1 integrin | ||
| 580 | +Mknk2 | ||
| 581 | +a-smooth muscle actin | ||
| 582 | +LPA1 | ||
| 583 | +WNT1-inducible signaling pathway protein 1 | ||
| 584 | +HAI-2 | ||
| 585 | +CD34 | ||
| 586 | +COL1A2 | ||
| 587 | +ERK | ||
| 588 | +Transforming growth factor TGF-b1 | ||
| 589 | +protease-activated receptor-2 | ||
| 590 | +PAR-2 | ||
| 591 | +Insulin-like growth factor binding protein-3 | ||
| 592 | +CXCL9 | ||
| 595 | TGF -b1 | 593 | TGF -b1 |
| 594 | +PHGDH | ||
| 595 | +IGFBP-1 | ... | ... |
-
Please register or login to post a comment